Ankar Pharma is a spin-off company born in the CSIC (Spanish Council for Research) that will help to accelerate the translation of basic research on drug discovery to clinical trials for severe human unmet diseases such as neurodegenerative disorders and metabolic diseases.
To minimize the risk and optimize the success, ANKAR PHARMA will work by different projects supported by different partners and collaborators. All of them will be focused on new drug candidates with innovative mechanism of action for diverse diseases where no effective treatment exists. The first efforts of the company are aimed to Multiple Sclerosis (MS).
Passion for healing is the spirit of ANKAR PHARMA that will require eventual partnering
with a pharmaceutical company for development its innovative drugs into the various clinical stages and market entry.